詳細検索

詳細検索

お問い合わせ

Global In Vitro Dagnostics for Haemostasis Market Growth (Status and Outlook) 2026-2032

Global In Vitro Dagnostics for Haemostasis Market Growth (Status and Outlook) 2026-2032


止血検査用体外診断の世界市場 2026-2032年

The global In Vitro Dagnostics for Haemostasis market size is predicted to grow from US$ 3313 million in 2025 to US$ 5825 million in 2032; it is expected to grow at a CAGR of 8.6% from 2026 to 2032... もっと見る

 

 

出版社
LP Information
LPインフォメーション
出版年月
2026年11月19日
電子版価格
US$3,660
シングルユーザーライセンス
ライセンス・価格情報/注文方法はこちら
納期
3-5営業日程度
ページ数
118
言語
英語

英語原文をAIを使って翻訳しています。


 

お問い合わせ

お問合せ種類/内容 *

補足が有ればご記入ください
貴社名*
ご担当者名 * 姓 名
メールアドレス *

ページTOPに戻る



図表リスト

List of Tables
Table 1. In Vitro Dagnostics for Haemostasis Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. In Vitro Dagnostics for Haemostasis Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Diagnostic Equipment
Table 4. Major Players of Diagnostic Reagents
Table 5. In Vitro Dagnostics for Haemostasis Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global In Vitro Dagnostics for Haemostasis Market Size by Type (2021-2026) & ($ millions)
Table 7. Global In Vitro Dagnostics for Haemostasis Market Size Market Share by Type (2021-2026)
Table 8. In Vitro Dagnostics for Haemostasis Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global In Vitro Dagnostics for Haemostasis Market Size by Application (2021-2026) & ($ millions)
Table 10. Global In Vitro Dagnostics for Haemostasis Market Size Market Share by Application (2021-2026)
Table 11. Global In Vitro Dagnostics for Haemostasis Revenue by Player (2021-2026) & ($ millions)
Table 12. Global In Vitro Dagnostics for Haemostasis Revenue Market Share by Player (2021-2026)
Table 13. In Vitro Dagnostics for Haemostasis Key Players Head office and Products Offered
Table 14. In Vitro Dagnostics for Haemostasis Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global In Vitro Dagnostics for Haemostasis Market Size by Region (2021-2026) & ($ millions)
Table 18. Global In Vitro Dagnostics for Haemostasis Market Size Market Share by Region (2021-2026)
Table 19. Global In Vitro Dagnostics for Haemostasis Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global In Vitro Dagnostics for Haemostasis Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas In Vitro Dagnostics for Haemostasis Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas In Vitro Dagnostics for Haemostasis Market Size Market Share by Country (2021-2026)
Table 23. Americas In Vitro Dagnostics for Haemostasis Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas In Vitro Dagnostics for Haemostasis Market Size Market Share by Type (2021-2026)
Table 25. Americas In Vitro Dagnostics for Haemostasis Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas In Vitro Dagnostics for Haemostasis Market Size Market Share by Application (2021-2026)
Table 27. APAC In Vitro Dagnostics for Haemostasis Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC In Vitro Dagnostics for Haemostasis Market Size Market Share by Region (2021-2026)
Table 29. APAC In Vitro Dagnostics for Haemostasis Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC In Vitro Dagnostics for Haemostasis Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe In Vitro Dagnostics for Haemostasis Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe In Vitro Dagnostics for Haemostasis Market Size Market Share by Country (2021-2026)
Table 33. Europe In Vitro Dagnostics for Haemostasis Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe In Vitro Dagnostics for Haemostasis Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa In Vitro Dagnostics for Haemostasis Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa In Vitro Dagnostics for Haemostasis Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa In Vitro Dagnostics for Haemostasis Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of In Vitro Dagnostics for Haemostasis
Table 39. Key Market Challenges & Risks of In Vitro Dagnostics for Haemostasis
Table 40. Key Industry Trends of In Vitro Dagnostics for Haemostasis
Table 41. Global In Vitro Dagnostics for Haemostasis Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global In Vitro Dagnostics for Haemostasis Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global In Vitro Dagnostics for Haemostasis Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global In Vitro Dagnostics for Haemostasis Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Sysmex Details, Company Type, In Vitro Dagnostics for Haemostasis Area Served and Its Competitors
Table 46. Sysmex In Vitro Dagnostics for Haemostasis Product Offered
Table 47. Sysmex In Vitro Dagnostics for Haemostasis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Sysmex Main Business
Table 49. Sysmex Latest Developments
Table 50. Stago Details, Company Type, In Vitro Dagnostics for Haemostasis Area Served and Its Competitors
Table 51. Stago In Vitro Dagnostics for Haemostasis Product Offered
Table 52. Stago In Vitro Dagnostics for Haemostasis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Stago Main Business
Table 54. Stago Latest Developments
Table 55. Werfen Details, Company Type, In Vitro Dagnostics for Haemostasis Area Served and Its Competitors
Table 56. Werfen In Vitro Dagnostics for Haemostasis Product Offered
Table 57. Werfen In Vitro Dagnostics for Haemostasis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Werfen Main Business
Table 59. Werfen Latest Developments
Table 60. Sekisui Medical Details, Company Type, In Vitro Dagnostics for Haemostasis Area Served and Its Competitors
Table 61. Sekisui Medical In Vitro Dagnostics for Haemostasis Product Offered
Table 62. Sekisui Medical In Vitro Dagnostics for Haemostasis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Sekisui Medical Main Business
Table 64. Sekisui Medical Latest Developments
Table 65. Behnk Elektronik (BE) Details, Company Type, In Vitro Dagnostics for Haemostasis Area Served and Its Competitors
Table 66. Behnk Elektronik (BE) In Vitro Dagnostics for Haemostasis Product Offered
Table 67. Behnk Elektronik (BE) In Vitro Dagnostics for Haemostasis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Behnk Elektronik (BE) Main Business
Table 69. Behnk Elektronik (BE) Latest Developments
Table 70. Roche Details, Company Type, In Vitro Dagnostics for Haemostasis Area Served and Its Competitors
Table 71. Roche In Vitro Dagnostics for Haemostasis Product Offered
Table 72. Roche In Vitro Dagnostics for Haemostasis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Roche Main Business
Table 74. Roche Latest Developments
Table 75. Thermo Fischer Details, Company Type, In Vitro Dagnostics for Haemostasis Area Served and Its Competitors
Table 76. Thermo Fischer In Vitro Dagnostics for Haemostasis Product Offered
Table 77. Thermo Fischer In Vitro Dagnostics for Haemostasis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Thermo Fischer Main Business
Table 79. Thermo Fischer Latest Developments
Table 80. Beijing Succeeder Technology Details, Company Type, In Vitro Dagnostics for Haemostasis Area Served and Its Competitors
Table 81. Beijing Succeeder Technology In Vitro Dagnostics for Haemostasis Product Offered
Table 82. Beijing Succeeder Technology In Vitro Dagnostics for Haemostasis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Beijing Succeeder Technology Main Business
Table 84. Beijing Succeeder Technology Latest Developments
Table 85. Mindray Medical Details, Company Type, In Vitro Dagnostics for Haemostasis Area Served and Its Competitors
Table 86. Mindray Medical In Vitro Dagnostics for Haemostasis Product Offered
Table 87. Mindray Medical In Vitro Dagnostics for Haemostasis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Mindray Medical Main Business
Table 89. Mindray Medical Latest Developments
Table 90. Shanghai Sun Biotechnology Details, Company Type, In Vitro Dagnostics for Haemostasis Area Served and Its Competitors
Table 91. Shanghai Sun Biotechnology In Vitro Dagnostics for Haemostasis Product Offered
Table 92. Shanghai Sun Biotechnology In Vitro Dagnostics for Haemostasis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Shanghai Sun Biotechnology Main Business
Table 94. Shanghai Sun Biotechnology Latest Developments
Table 95. Rayto Life and Analytical Sciences Details, Company Type, In Vitro Dagnostics for Haemostasis Area Served and Its Competitors
Table 96. Rayto Life and Analytical Sciences In Vitro Dagnostics for Haemostasis Product Offered
Table 97. Rayto Life and Analytical Sciences In Vitro Dagnostics for Haemostasis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Rayto Life and Analytical Sciences Main Business
Table 99. Rayto Life and Analytical Sciences Latest Developments
Table 100. Beijing ZONCI Technology Development Details, Company Type, In Vitro Dagnostics for Haemostasis Area Served and Its Competitors
Table 101. Beijing ZONCI Technology Development In Vitro Dagnostics for Haemostasis Product Offered
Table 102. Beijing ZONCI Technology Development In Vitro Dagnostics for Haemostasis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Beijing ZONCI Technology Development Main Business
Table 104. Beijing ZONCI Technology Development Latest Developments
Table 105. Shenzhen Dymind Biotechnology Details, Company Type, In Vitro Dagnostics for Haemostasis Area Served and Its Competitors
Table 106. Shenzhen Dymind Biotechnology In Vitro Dagnostics for Haemostasis Product Offered
Table 107. Shenzhen Dymind Biotechnology In Vitro Dagnostics for Haemostasis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Shenzhen Dymind Biotechnology Main Business
Table 109. Shenzhen Dymind Biotechnology Latest Developments
Table 110. TECO Details, Company Type, In Vitro Dagnostics for Haemostasis Area Served and Its Competitors
Table 111. TECO In Vitro Dagnostics for Haemostasis Product Offered
Table 112. TECO In Vitro Dagnostics for Haemostasis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. TECO Main Business
Table 114. TECO Latest Developments
Table 115. ACCURDX Details, Company Type, In Vitro Dagnostics for Haemostasis Area Served and Its Competitors
Table 116. ACCURDX In Vitro Dagnostics for Haemostasis Product Offered
Table 117. ACCURDX In Vitro Dagnostics for Haemostasis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. ACCURDX Main Business
Table 119. ACCURDX Latest Developments

List of Figures
Figure 1. In Vitro Dagnostics for Haemostasis Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global In Vitro Dagnostics for Haemostasis Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. In Vitro Dagnostics for Haemostasis Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. In Vitro Dagnostics for Haemostasis Sales Market Share by Country/Region (2025)
Figure 8. In Vitro Dagnostics for Haemostasis Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global In Vitro Dagnostics for Haemostasis Market Size Market Share by Type in 2025
Figure 10. In Vitro Dagnostics for Haemostasis in Hospital
Figure 11. Global In Vitro Dagnostics for Haemostasis Market: Hospital (2021-2026) & ($ millions)
Figure 12. In Vitro Dagnostics for Haemostasis in Research Institutions
Figure 13. Global In Vitro Dagnostics for Haemostasis Market: Research Institutions (2021-2026) & ($ millions)
Figure 14. In Vitro Dagnostics for Haemostasis in Diagnostic Centers
Figure 15. Global In Vitro Dagnostics for Haemostasis Market: Diagnostic Centers (2021-2026) & ($ millions)
Figure 16. In Vitro Dagnostics for Haemostasis in Other
Figure 17. Global In Vitro Dagnostics for Haemostasis Market: Other (2021-2026) & ($ millions)
Figure 18. Global In Vitro Dagnostics for Haemostasis Market Size Market Share by Application in 2025
Figure 19. Global In Vitro Dagnostics for Haemostasis Revenue Market Share by Player in 2025
Figure 20. Global In Vitro Dagnostics for Haemostasis Market Size Market Share by Region (2021-2026)
Figure 21. Americas In Vitro Dagnostics for Haemostasis Market Size 2021-2026 ($ millions)
Figure 22. APAC In Vitro Dagnostics for Haemostasis Market Size 2021-2026 ($ millions)
Figure 23. Europe In Vitro Dagnostics for Haemostasis Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa In Vitro Dagnostics for Haemostasis Market Size 2021-2026 ($ millions)
Figure 25. Americas In Vitro Dagnostics for Haemostasis Value Market Share by Country in 2025
Figure 26. United States In Vitro Dagnostics for Haemostasis Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada In Vitro Dagnostics for Haemostasis Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico In Vitro Dagnostics for Haemostasis Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil In Vitro Dagnostics for Haemostasis Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC In Vitro Dagnostics for Haemostasis Market Size Market Share by Region in 2025
Figure 31. APAC In Vitro Dagnostics for Haemostasis Market Size Market Share by Type (2021-2026)
Figure 32. APAC In Vitro Dagnostics for Haemostasis Market Size Market Share by Application (2021-2026)
Figure 33. China In Vitro Dagnostics for Haemostasis Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan In Vitro Dagnostics for Haemostasis Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea In Vitro Dagnostics for Haemostasis Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia In Vitro Dagnostics for Haemostasis Market Size Growth 2021-2026 ($ millions)
Figure 37. India In Vitro Dagnostics for Haemostasis Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia In Vitro Dagnostics for Haemostasis Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe In Vitro Dagnostics for Haemostasis Market Size Market Share by Country in 2025
Figure 40. Europe In Vitro Dagnostics for Haemostasis Market Size Market Share by Type (2021-2026)
Figure 41. Europe In Vitro Dagnostics for Haemostasis Market Size Market Share by Application (2021-2026)
Figure 42. Germany In Vitro Dagnostics for Haemostasis Market Size Growth 2021-2026 ($ millions)
Figure 43. France In Vitro Dagnostics for Haemostasis Market Size Growth 2021-2026 ($ millions)
Figure 44. UK In Vitro Dagnostics for Haemostasis Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy In Vitro Dagnostics for Haemostasis Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia In Vitro Dagnostics for Haemostasis Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa In Vitro Dagnostics for Haemostasis Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa In Vitro Dagnostics for Haemostasis Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa In Vitro Dagnostics for Haemostasis Market Size Market Share by Application (2021-2026)
Figure 50. Egypt In Vitro Dagnostics for Haemostasis Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa In Vitro Dagnostics for Haemostasis Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel In Vitro Dagnostics for Haemostasis Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey In Vitro Dagnostics for Haemostasis Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries In Vitro Dagnostics for Haemostasis Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas In Vitro Dagnostics for Haemostasis Market Size 2027-2032 ($ millions)
Figure 56. APAC In Vitro Dagnostics for Haemostasis Market Size 2027-2032 ($ millions)
Figure 57. Europe In Vitro Dagnostics for Haemostasis Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa In Vitro Dagnostics for Haemostasis Market Size 2027-2032 ($ millions)
Figure 59. United States In Vitro Dagnostics for Haemostasis Market Size 2027-2032 ($ millions)
Figure 60. Canada In Vitro Dagnostics for Haemostasis Market Size 2027-2032 ($ millions)
Figure 61. Mexico In Vitro Dagnostics for Haemostasis Market Size 2027-2032 ($ millions)
Figure 62. Brazil In Vitro Dagnostics for Haemostasis Market Size 2027-2032 ($ millions)
Figure 63. China In Vitro Dagnostics for Haemostasis Market Size 2027-2032 ($ millions)
Figure 64. Japan In Vitro Dagnostics for Haemostasis Market Size 2027-2032 ($ millions)
Figure 65. Korea In Vitro Dagnostics for Haemostasis Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia In Vitro Dagnostics for Haemostasis Market Size 2027-2032 ($ millions)
Figure 67. India In Vitro Dagnostics for Haemostasis Market Size 2027-2032 ($ millions)
Figure 68. Australia In Vitro Dagnostics for Haemostasis Market Size 2027-2032 ($ millions)
Figure 69. Germany In Vitro Dagnostics for Haemostasis Market Size 2027-2032 ($ millions)
Figure 70. France In Vitro Dagnostics for Haemostasis Market Size 2027-2032 ($ millions)
Figure 71. UK In Vitro Dagnostics for Haemostasis Market Size 2027-2032 ($ millions)
Figure 72. Italy In Vitro Dagnostics for Haemostasis Market Size 2027-2032 ($ millions)
Figure 73. Russia In Vitro Dagnostics for Haemostasis Market Size 2027-2032 ($ millions)
Figure 74. Egypt In Vitro Dagnostics for Haemostasis Market Size 2027-2032 ($ millions)
Figure 75. South Africa In Vitro Dagnostics for Haemostasis Market Size 2027-2032 ($ millions)
Figure 76. Israel In Vitro Dagnostics for Haemostasis Market Size 2027-2032 ($ millions)
Figure 77. Turkey In Vitro Dagnostics for Haemostasis Market Size 2027-2032 ($ millions)
Figure 78. Global In Vitro Dagnostics for Haemostasis Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global In Vitro Dagnostics for Haemostasis Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries In Vitro Dagnostics for Haemostasis Market Size 2027-2032 ($ millions)

 

ページTOPに戻る


 

Summary

The global In Vitro Dagnostics for Haemostasis market size is predicted to grow from US$ 3313 million in 2025 to US$ 5825 million in 2032; it is expected to grow at a CAGR of 8.6% from 2026 to 2032.

In vitro diagnostics for haemostasis refers to laboratory-based testing conducted outside the human body to evaluate the blood's ability to maintain hemostasis—preventing both excessive bleeding and unwanted clot formation. These tests are performed using blood or plasma samples, and rely on specialized instruments, reagents, and assay protocols. They assess factors such as clotting time, fibrin formation, platelet function, and fibrinolysis. Common tests include Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT), Thrombin Time (TT), Fibrinogen concentration, D-dimer levels, and advanced assays such as thromboelastography (TEG) and anti-Xa activity. These diagnostics are essential for managing bleeding disorders, thrombotic diseases, surgical risks, and anticoagulant therapy.

In vitro diagnostics for haemostasis has become an essential part of modern laboratory medicine, especially as personalized healthcare and risk stratification gain importance in clinical practice. With the growing complexity of patient care—ranging from cardiovascular surgery and oncology treatment to chronic disease management—the need for precise, efficient, and reliable coagulation testing is steadily increasing. Hospitals and diagnostic laboratories are investing in automated coagulation analyzers and comprehensive reagent systems to handle routine and specialized testing with high accuracy and low turnaround time. These systems are often integrated into broader laboratory automation platforms to streamline workflow and improve result consistency.

In the Chinese medical context, the application of haemostasis IVD has expanded rapidly, driven by the increased prevalence of thrombosis-related conditions and the widespread use of anticoagulant drugs in both outpatient and inpatient settings. From tertiary hospitals to regional healthcare facilities, the emphasis on early diagnosis, perioperative safety, and treatment monitoring has made haemostasis diagnostics a standard component of clinical decision-making. Additionally, the development of domestic brands and reagent systems has lowered testing costs and improved access to advanced diagnostics in lower-tier cities and rural hospitals. Beyond traditional clotting tests, demand for personalized profiles—such as TEG, platelet mapping, and global coagulation assays—is gradually rising, reflecting the shift toward more dynamic, patient-specific diagnostics. As clinical pathways evolve, haemostasis IVD will play an increasingly central role in improving patient safety and treatment outcomes.

Report Scope
LPI (LP Information)' newest research report, the “In Vitro Dagnostics for Haemostasis Industry Forecast” looks at past sales and reviews total world In Vitro Dagnostics for Haemostasis sales in 2025, providing a comprehensive analysis by region and market sector of projected In Vitro Dagnostics for Haemostasis sales for 2026 through 2032. With In Vitro Dagnostics for Haemostasis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world In Vitro Dagnostics for Haemostasis industry.

This Insight Report provides a comprehensive analysis of the global In Vitro Dagnostics for Haemostasis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on In Vitro Dagnostics for Haemostasis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global In Vitro Dagnostics for Haemostasis market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for In Vitro Dagnostics for Haemostasis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global In Vitro Dagnostics for Haemostasis.

This report presents a comprehensive overview, market shares, and growth opportunities of In Vitro Dagnostics for Haemostasis market by product type, application, key players and key regions and countries.

Market Segmentation
Segmentation by Type:
Diagnostic Equipment
Diagnostic Reagents

Segmentation by Application:
Hospital
Research Institutions
Diagnostic Centers
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

Sysmex
Stago
Werfen
Sekisui Medical
Behnk Elektronik (BE)
Roche
Thermo Fischer
Beijing Succeeder Technology
Mindray Medical
Shanghai Sun Biotechnology
Rayto Life and Analytical Sciences
Beijing ZONCI Technology Development
Shenzhen Dymind Biotechnology
TECO
ACCURDX

ページTOPに戻る


Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 Executive Summary
2.1 World Market Overview
2.1.1 Global In Vitro Dagnostics for Haemostasis Market Size (2021-2032)
2.1.2 In Vitro Dagnostics for Haemostasis Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for In Vitro Dagnostics for Haemostasis by Country/Region (2021, 2025 & 2032)
2.2 In Vitro Dagnostics for Haemostasis Segment by Type
2.2.1 Diagnostic Equipment
2.2.2 Diagnostic Reagents
2.2.3 In Vitro Dagnostics for Haemostasis Market Size by Type
2.2.3.1 In Vitro Dagnostics for Haemostasis Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global In Vitro Dagnostics for Haemostasis Market Size Market Share by Type (2021-2026)
2.3 In Vitro Dagnostics for Haemostasis Segment by Application
2.3.1 Hospital
2.3.2 Research Institutions
2.3.3 Diagnostic Centers
2.3.4 Other
2.3.5 In Vitro Dagnostics for Haemostasis Market Size by Application
2.3.5.1 In Vitro Dagnostics for Haemostasis Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.5.2 Global In Vitro Dagnostics for Haemostasis Market Size Market Share by Application (2021-2026)

3 In Vitro Dagnostics for Haemostasis Market Size by Player
3.1 In Vitro Dagnostics for Haemostasis Market Size Market Share by Player
3.1.1 Global In Vitro Dagnostics for Haemostasis Revenue by Player (2021-2026)
3.1.2 Global In Vitro Dagnostics for Haemostasis Revenue Market Share by Player (2021-2026)
3.2 Global In Vitro Dagnostics for Haemostasis Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 In Vitro Dagnostics for Haemostasis by Region
4.1 In Vitro Dagnostics for Haemostasis Market Size by Region (2021-2026)
4.2 Global In Vitro Dagnostics for Haemostasis Annual Revenue by Country/Region (2021-2026)
4.3 Americas In Vitro Dagnostics for Haemostasis Market Size Growth (2021-2026)
4.4 APAC In Vitro Dagnostics for Haemostasis Market Size Growth (2021-2026)
4.5 Europe In Vitro Dagnostics for Haemostasis Market Size Growth (2021-2026)
4.6 Middle East & Africa In Vitro Dagnostics for Haemostasis Market Size Growth (2021-2026)

5 Americas
5.1 Americas In Vitro Dagnostics for Haemostasis Market Size by Country (2021-2026)
5.2 Americas In Vitro Dagnostics for Haemostasis Market Size by Type (2021-2026)
5.3 Americas In Vitro Dagnostics for Haemostasis Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC In Vitro Dagnostics for Haemostasis Market Size by Region (2021-2026)
6.2 APAC In Vitro Dagnostics for Haemostasis Market Size by Type (2021-2026)
6.3 APAC In Vitro Dagnostics for Haemostasis Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe In Vitro Dagnostics for Haemostasis Market Size by Country (2021-2026)
7.2 Europe In Vitro Dagnostics for Haemostasis Market Size by Type (2021-2026)
7.3 Europe In Vitro Dagnostics for Haemostasis Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa In Vitro Dagnostics for Haemostasis by Region (2021-2026)
8.2 Middle East & Africa In Vitro Dagnostics for Haemostasis Market Size by Type (2021-2026)
8.3 Middle East & Africa In Vitro Dagnostics for Haemostasis Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 Global In Vitro Dagnostics for Haemostasis Market Forecast
10.1 Global In Vitro Dagnostics for Haemostasis Forecast by Region (2027-2032)
10.1.1 Global In Vitro Dagnostics for Haemostasis Forecast by Region (2027-2032)
10.1.2 Americas In Vitro Dagnostics for Haemostasis Forecast
10.1.3 APAC In Vitro Dagnostics for Haemostasis Forecast
10.1.4 Europe In Vitro Dagnostics for Haemostasis Forecast
10.1.5 Middle East & Africa In Vitro Dagnostics for Haemostasis Forecast
10.2 Americas In Vitro Dagnostics for Haemostasis Forecast by Country (2027-2032)
10.2.1 United States Market In Vitro Dagnostics for Haemostasis Forecast
10.2.2 Canada Market In Vitro Dagnostics for Haemostasis Forecast
10.2.3 Mexico Market In Vitro Dagnostics for Haemostasis Forecast
10.2.4 Brazil Market In Vitro Dagnostics for Haemostasis Forecast
10.3 APAC In Vitro Dagnostics for Haemostasis Forecast by Region (2027-2032)
10.3.1 China In Vitro Dagnostics for Haemostasis Market Forecast
10.3.2 Japan Market In Vitro Dagnostics for Haemostasis Forecast
10.3.3 Korea Market In Vitro Dagnostics for Haemostasis Forecast
10.3.4 Southeast Asia Market In Vitro Dagnostics for Haemostasis Forecast
10.3.5 India Market In Vitro Dagnostics for Haemostasis Forecast
10.3.6 Australia Market In Vitro Dagnostics for Haemostasis Forecast
10.4 Europe In Vitro Dagnostics for Haemostasis Forecast by Country (2027-2032)
10.4.1 Germany Market In Vitro Dagnostics for Haemostasis Forecast
10.4.2 France Market In Vitro Dagnostics for Haemostasis Forecast
10.4.3 UK Market In Vitro Dagnostics for Haemostasis Forecast
10.4.4 Italy Market In Vitro Dagnostics for Haemostasis Forecast
10.4.5 Russia Market In Vitro Dagnostics for Haemostasis Forecast
10.5 Middle East & Africa In Vitro Dagnostics for Haemostasis Forecast by Region (2027-2032)
10.5.1 Egypt Market In Vitro Dagnostics for Haemostasis Forecast
10.5.2 South Africa Market In Vitro Dagnostics for Haemostasis Forecast
10.5.3 Israel Market In Vitro Dagnostics for Haemostasis Forecast
10.5.4 Turkey Market In Vitro Dagnostics for Haemostasis Forecast
10.6 Global In Vitro Dagnostics for Haemostasis Forecast by Type (2027-2032)
10.7 Global In Vitro Dagnostics for Haemostasis Forecast by Application (2027-2032)
10.7.1 GCC Countries Market In Vitro Dagnostics for Haemostasis Forecast

11 Key Players Analysis
11.1 Sysmex
11.1.1 Sysmex Company Information
11.1.2 Sysmex In Vitro Dagnostics for Haemostasis Product Offered
11.1.3 Sysmex In Vitro Dagnostics for Haemostasis Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Sysmex Main Business Overview
11.1.5 Sysmex Latest Developments
11.2 Stago
11.2.1 Stago Company Information
11.2.2 Stago In Vitro Dagnostics for Haemostasis Product Offered
11.2.3 Stago In Vitro Dagnostics for Haemostasis Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Stago Main Business Overview
11.2.5 Stago Latest Developments
11.3 Werfen
11.3.1 Werfen Company Information
11.3.2 Werfen In Vitro Dagnostics for Haemostasis Product Offered
11.3.3 Werfen In Vitro Dagnostics for Haemostasis Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Werfen Main Business Overview
11.3.5 Werfen Latest Developments
11.4 Sekisui Medical
11.4.1 Sekisui Medical Company Information
11.4.2 Sekisui Medical In Vitro Dagnostics for Haemostasis Product Offered
11.4.3 Sekisui Medical In Vitro Dagnostics for Haemostasis Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Sekisui Medical Main Business Overview
11.4.5 Sekisui Medical Latest Developments
11.5 Behnk Elektronik (BE)
11.5.1 Behnk Elektronik (BE) Company Information
11.5.2 Behnk Elektronik (BE) In Vitro Dagnostics for Haemostasis Product Offered
11.5.3 Behnk Elektronik (BE) In Vitro Dagnostics for Haemostasis Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Behnk Elektronik (BE) Main Business Overview
11.5.5 Behnk Elektronik (BE) Latest Developments
11.6 Roche
11.6.1 Roche Company Information
11.6.2 Roche In Vitro Dagnostics for Haemostasis Product Offered
11.6.3 Roche In Vitro Dagnostics for Haemostasis Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Roche Main Business Overview
11.6.5 Roche Latest Developments
11.7 Thermo Fischer
11.7.1 Thermo Fischer Company Information
11.7.2 Thermo Fischer In Vitro Dagnostics for Haemostasis Product Offered
11.7.3 Thermo Fischer In Vitro Dagnostics for Haemostasis Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Thermo Fischer Main Business Overview
11.7.5 Thermo Fischer Latest Developments
11.8 Beijing Succeeder Technology
11.8.1 Beijing Succeeder Technology Company Information
11.8.2 Beijing Succeeder Technology In Vitro Dagnostics for Haemostasis Product Offered
11.8.3 Beijing Succeeder Technology In Vitro Dagnostics for Haemostasis Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Beijing Succeeder Technology Main Business Overview
11.8.5 Beijing Succeeder Technology Latest Developments
11.9 Mindray Medical
11.9.1 Mindray Medical Company Information
11.9.2 Mindray Medical In Vitro Dagnostics for Haemostasis Product Offered
11.9.3 Mindray Medical In Vitro Dagnostics for Haemostasis Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Mindray Medical Main Business Overview
11.9.5 Mindray Medical Latest Developments
11.10 Shanghai Sun Biotechnology
11.10.1 Shanghai Sun Biotechnology Company Information
11.10.2 Shanghai Sun Biotechnology In Vitro Dagnostics for Haemostasis Product Offered
11.10.3 Shanghai Sun Biotechnology In Vitro Dagnostics for Haemostasis Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Shanghai Sun Biotechnology Main Business Overview
11.10.5 Shanghai Sun Biotechnology Latest Developments
11.11 Rayto Life and Analytical Sciences
11.11.1 Rayto Life and Analytical Sciences Company Information
11.11.2 Rayto Life and Analytical Sciences In Vitro Dagnostics for Haemostasis Product Offered
11.11.3 Rayto Life and Analytical Sciences In Vitro Dagnostics for Haemostasis Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Rayto Life and Analytical Sciences Main Business Overview
11.11.5 Rayto Life and Analytical Sciences Latest Developments
11.12 Beijing ZONCI Technology Development
11.12.1 Beijing ZONCI Technology Development Company Information
11.12.2 Beijing ZONCI Technology Development In Vitro Dagnostics for Haemostasis Product Offered
11.12.3 Beijing ZONCI Technology Development In Vitro Dagnostics for Haemostasis Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Beijing ZONCI Technology Development Main Business Overview
11.12.5 Beijing ZONCI Technology Development Latest Developments
11.13 Shenzhen Dymind Biotechnology
11.13.1 Shenzhen Dymind Biotechnology Company Information
11.13.2 Shenzhen Dymind Biotechnology In Vitro Dagnostics for Haemostasis Product Offered
11.13.3 Shenzhen Dymind Biotechnology In Vitro Dagnostics for Haemostasis Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Shenzhen Dymind Biotechnology Main Business Overview
11.13.5 Shenzhen Dymind Biotechnology Latest Developments
11.14 TECO
11.14.1 TECO Company Information
11.14.2 TECO In Vitro Dagnostics for Haemostasis Product Offered
11.14.3 TECO In Vitro Dagnostics for Haemostasis Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 TECO Main Business Overview
11.14.5 TECO Latest Developments
11.15 ACCURDX
11.15.1 ACCURDX Company Information
11.15.2 ACCURDX In Vitro Dagnostics for Haemostasis Product Offered
11.15.3 ACCURDX In Vitro Dagnostics for Haemostasis Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 ACCURDX Main Business Overview
11.15.5 ACCURDX Latest Developments

12 Research Findings and Conclusion

ページTOPに戻る



List of Tables/Graphs

List of Tables
Table 1. In Vitro Dagnostics for Haemostasis Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. In Vitro Dagnostics for Haemostasis Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Diagnostic Equipment
Table 4. Major Players of Diagnostic Reagents
Table 5. In Vitro Dagnostics for Haemostasis Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global In Vitro Dagnostics for Haemostasis Market Size by Type (2021-2026) & ($ millions)
Table 7. Global In Vitro Dagnostics for Haemostasis Market Size Market Share by Type (2021-2026)
Table 8. In Vitro Dagnostics for Haemostasis Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global In Vitro Dagnostics for Haemostasis Market Size by Application (2021-2026) & ($ millions)
Table 10. Global In Vitro Dagnostics for Haemostasis Market Size Market Share by Application (2021-2026)
Table 11. Global In Vitro Dagnostics for Haemostasis Revenue by Player (2021-2026) & ($ millions)
Table 12. Global In Vitro Dagnostics for Haemostasis Revenue Market Share by Player (2021-2026)
Table 13. In Vitro Dagnostics for Haemostasis Key Players Head office and Products Offered
Table 14. In Vitro Dagnostics for Haemostasis Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global In Vitro Dagnostics for Haemostasis Market Size by Region (2021-2026) & ($ millions)
Table 18. Global In Vitro Dagnostics for Haemostasis Market Size Market Share by Region (2021-2026)
Table 19. Global In Vitro Dagnostics for Haemostasis Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global In Vitro Dagnostics for Haemostasis Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas In Vitro Dagnostics for Haemostasis Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas In Vitro Dagnostics for Haemostasis Market Size Market Share by Country (2021-2026)
Table 23. Americas In Vitro Dagnostics for Haemostasis Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas In Vitro Dagnostics for Haemostasis Market Size Market Share by Type (2021-2026)
Table 25. Americas In Vitro Dagnostics for Haemostasis Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas In Vitro Dagnostics for Haemostasis Market Size Market Share by Application (2021-2026)
Table 27. APAC In Vitro Dagnostics for Haemostasis Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC In Vitro Dagnostics for Haemostasis Market Size Market Share by Region (2021-2026)
Table 29. APAC In Vitro Dagnostics for Haemostasis Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC In Vitro Dagnostics for Haemostasis Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe In Vitro Dagnostics for Haemostasis Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe In Vitro Dagnostics for Haemostasis Market Size Market Share by Country (2021-2026)
Table 33. Europe In Vitro Dagnostics for Haemostasis Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe In Vitro Dagnostics for Haemostasis Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa In Vitro Dagnostics for Haemostasis Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa In Vitro Dagnostics for Haemostasis Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa In Vitro Dagnostics for Haemostasis Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of In Vitro Dagnostics for Haemostasis
Table 39. Key Market Challenges & Risks of In Vitro Dagnostics for Haemostasis
Table 40. Key Industry Trends of In Vitro Dagnostics for Haemostasis
Table 41. Global In Vitro Dagnostics for Haemostasis Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global In Vitro Dagnostics for Haemostasis Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global In Vitro Dagnostics for Haemostasis Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global In Vitro Dagnostics for Haemostasis Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Sysmex Details, Company Type, In Vitro Dagnostics for Haemostasis Area Served and Its Competitors
Table 46. Sysmex In Vitro Dagnostics for Haemostasis Product Offered
Table 47. Sysmex In Vitro Dagnostics for Haemostasis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Sysmex Main Business
Table 49. Sysmex Latest Developments
Table 50. Stago Details, Company Type, In Vitro Dagnostics for Haemostasis Area Served and Its Competitors
Table 51. Stago In Vitro Dagnostics for Haemostasis Product Offered
Table 52. Stago In Vitro Dagnostics for Haemostasis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Stago Main Business
Table 54. Stago Latest Developments
Table 55. Werfen Details, Company Type, In Vitro Dagnostics for Haemostasis Area Served and Its Competitors
Table 56. Werfen In Vitro Dagnostics for Haemostasis Product Offered
Table 57. Werfen In Vitro Dagnostics for Haemostasis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Werfen Main Business
Table 59. Werfen Latest Developments
Table 60. Sekisui Medical Details, Company Type, In Vitro Dagnostics for Haemostasis Area Served and Its Competitors
Table 61. Sekisui Medical In Vitro Dagnostics for Haemostasis Product Offered
Table 62. Sekisui Medical In Vitro Dagnostics for Haemostasis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Sekisui Medical Main Business
Table 64. Sekisui Medical Latest Developments
Table 65. Behnk Elektronik (BE) Details, Company Type, In Vitro Dagnostics for Haemostasis Area Served and Its Competitors
Table 66. Behnk Elektronik (BE) In Vitro Dagnostics for Haemostasis Product Offered
Table 67. Behnk Elektronik (BE) In Vitro Dagnostics for Haemostasis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Behnk Elektronik (BE) Main Business
Table 69. Behnk Elektronik (BE) Latest Developments
Table 70. Roche Details, Company Type, In Vitro Dagnostics for Haemostasis Area Served and Its Competitors
Table 71. Roche In Vitro Dagnostics for Haemostasis Product Offered
Table 72. Roche In Vitro Dagnostics for Haemostasis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Roche Main Business
Table 74. Roche Latest Developments
Table 75. Thermo Fischer Details, Company Type, In Vitro Dagnostics for Haemostasis Area Served and Its Competitors
Table 76. Thermo Fischer In Vitro Dagnostics for Haemostasis Product Offered
Table 77. Thermo Fischer In Vitro Dagnostics for Haemostasis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Thermo Fischer Main Business
Table 79. Thermo Fischer Latest Developments
Table 80. Beijing Succeeder Technology Details, Company Type, In Vitro Dagnostics for Haemostasis Area Served and Its Competitors
Table 81. Beijing Succeeder Technology In Vitro Dagnostics for Haemostasis Product Offered
Table 82. Beijing Succeeder Technology In Vitro Dagnostics for Haemostasis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Beijing Succeeder Technology Main Business
Table 84. Beijing Succeeder Technology Latest Developments
Table 85. Mindray Medical Details, Company Type, In Vitro Dagnostics for Haemostasis Area Served and Its Competitors
Table 86. Mindray Medical In Vitro Dagnostics for Haemostasis Product Offered
Table 87. Mindray Medical In Vitro Dagnostics for Haemostasis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Mindray Medical Main Business
Table 89. Mindray Medical Latest Developments
Table 90. Shanghai Sun Biotechnology Details, Company Type, In Vitro Dagnostics for Haemostasis Area Served and Its Competitors
Table 91. Shanghai Sun Biotechnology In Vitro Dagnostics for Haemostasis Product Offered
Table 92. Shanghai Sun Biotechnology In Vitro Dagnostics for Haemostasis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Shanghai Sun Biotechnology Main Business
Table 94. Shanghai Sun Biotechnology Latest Developments
Table 95. Rayto Life and Analytical Sciences Details, Company Type, In Vitro Dagnostics for Haemostasis Area Served and Its Competitors
Table 96. Rayto Life and Analytical Sciences In Vitro Dagnostics for Haemostasis Product Offered
Table 97. Rayto Life and Analytical Sciences In Vitro Dagnostics for Haemostasis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Rayto Life and Analytical Sciences Main Business
Table 99. Rayto Life and Analytical Sciences Latest Developments
Table 100. Beijing ZONCI Technology Development Details, Company Type, In Vitro Dagnostics for Haemostasis Area Served and Its Competitors
Table 101. Beijing ZONCI Technology Development In Vitro Dagnostics for Haemostasis Product Offered
Table 102. Beijing ZONCI Technology Development In Vitro Dagnostics for Haemostasis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Beijing ZONCI Technology Development Main Business
Table 104. Beijing ZONCI Technology Development Latest Developments
Table 105. Shenzhen Dymind Biotechnology Details, Company Type, In Vitro Dagnostics for Haemostasis Area Served and Its Competitors
Table 106. Shenzhen Dymind Biotechnology In Vitro Dagnostics for Haemostasis Product Offered
Table 107. Shenzhen Dymind Biotechnology In Vitro Dagnostics for Haemostasis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Shenzhen Dymind Biotechnology Main Business
Table 109. Shenzhen Dymind Biotechnology Latest Developments
Table 110. TECO Details, Company Type, In Vitro Dagnostics for Haemostasis Area Served and Its Competitors
Table 111. TECO In Vitro Dagnostics for Haemostasis Product Offered
Table 112. TECO In Vitro Dagnostics for Haemostasis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. TECO Main Business
Table 114. TECO Latest Developments
Table 115. ACCURDX Details, Company Type, In Vitro Dagnostics for Haemostasis Area Served and Its Competitors
Table 116. ACCURDX In Vitro Dagnostics for Haemostasis Product Offered
Table 117. ACCURDX In Vitro Dagnostics for Haemostasis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. ACCURDX Main Business
Table 119. ACCURDX Latest Developments

List of Figures
Figure 1. In Vitro Dagnostics for Haemostasis Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global In Vitro Dagnostics for Haemostasis Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. In Vitro Dagnostics for Haemostasis Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. In Vitro Dagnostics for Haemostasis Sales Market Share by Country/Region (2025)
Figure 8. In Vitro Dagnostics for Haemostasis Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global In Vitro Dagnostics for Haemostasis Market Size Market Share by Type in 2025
Figure 10. In Vitro Dagnostics for Haemostasis in Hospital
Figure 11. Global In Vitro Dagnostics for Haemostasis Market: Hospital (2021-2026) & ($ millions)
Figure 12. In Vitro Dagnostics for Haemostasis in Research Institutions
Figure 13. Global In Vitro Dagnostics for Haemostasis Market: Research Institutions (2021-2026) & ($ millions)
Figure 14. In Vitro Dagnostics for Haemostasis in Diagnostic Centers
Figure 15. Global In Vitro Dagnostics for Haemostasis Market: Diagnostic Centers (2021-2026) & ($ millions)
Figure 16. In Vitro Dagnostics for Haemostasis in Other
Figure 17. Global In Vitro Dagnostics for Haemostasis Market: Other (2021-2026) & ($ millions)
Figure 18. Global In Vitro Dagnostics for Haemostasis Market Size Market Share by Application in 2025
Figure 19. Global In Vitro Dagnostics for Haemostasis Revenue Market Share by Player in 2025
Figure 20. Global In Vitro Dagnostics for Haemostasis Market Size Market Share by Region (2021-2026)
Figure 21. Americas In Vitro Dagnostics for Haemostasis Market Size 2021-2026 ($ millions)
Figure 22. APAC In Vitro Dagnostics for Haemostasis Market Size 2021-2026 ($ millions)
Figure 23. Europe In Vitro Dagnostics for Haemostasis Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa In Vitro Dagnostics for Haemostasis Market Size 2021-2026 ($ millions)
Figure 25. Americas In Vitro Dagnostics for Haemostasis Value Market Share by Country in 2025
Figure 26. United States In Vitro Dagnostics for Haemostasis Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada In Vitro Dagnostics for Haemostasis Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico In Vitro Dagnostics for Haemostasis Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil In Vitro Dagnostics for Haemostasis Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC In Vitro Dagnostics for Haemostasis Market Size Market Share by Region in 2025
Figure 31. APAC In Vitro Dagnostics for Haemostasis Market Size Market Share by Type (2021-2026)
Figure 32. APAC In Vitro Dagnostics for Haemostasis Market Size Market Share by Application (2021-2026)
Figure 33. China In Vitro Dagnostics for Haemostasis Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan In Vitro Dagnostics for Haemostasis Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea In Vitro Dagnostics for Haemostasis Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia In Vitro Dagnostics for Haemostasis Market Size Growth 2021-2026 ($ millions)
Figure 37. India In Vitro Dagnostics for Haemostasis Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia In Vitro Dagnostics for Haemostasis Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe In Vitro Dagnostics for Haemostasis Market Size Market Share by Country in 2025
Figure 40. Europe In Vitro Dagnostics for Haemostasis Market Size Market Share by Type (2021-2026)
Figure 41. Europe In Vitro Dagnostics for Haemostasis Market Size Market Share by Application (2021-2026)
Figure 42. Germany In Vitro Dagnostics for Haemostasis Market Size Growth 2021-2026 ($ millions)
Figure 43. France In Vitro Dagnostics for Haemostasis Market Size Growth 2021-2026 ($ millions)
Figure 44. UK In Vitro Dagnostics for Haemostasis Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy In Vitro Dagnostics for Haemostasis Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia In Vitro Dagnostics for Haemostasis Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa In Vitro Dagnostics for Haemostasis Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa In Vitro Dagnostics for Haemostasis Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa In Vitro Dagnostics for Haemostasis Market Size Market Share by Application (2021-2026)
Figure 50. Egypt In Vitro Dagnostics for Haemostasis Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa In Vitro Dagnostics for Haemostasis Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel In Vitro Dagnostics for Haemostasis Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey In Vitro Dagnostics for Haemostasis Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries In Vitro Dagnostics for Haemostasis Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas In Vitro Dagnostics for Haemostasis Market Size 2027-2032 ($ millions)
Figure 56. APAC In Vitro Dagnostics for Haemostasis Market Size 2027-2032 ($ millions)
Figure 57. Europe In Vitro Dagnostics for Haemostasis Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa In Vitro Dagnostics for Haemostasis Market Size 2027-2032 ($ millions)
Figure 59. United States In Vitro Dagnostics for Haemostasis Market Size 2027-2032 ($ millions)
Figure 60. Canada In Vitro Dagnostics for Haemostasis Market Size 2027-2032 ($ millions)
Figure 61. Mexico In Vitro Dagnostics for Haemostasis Market Size 2027-2032 ($ millions)
Figure 62. Brazil In Vitro Dagnostics for Haemostasis Market Size 2027-2032 ($ millions)
Figure 63. China In Vitro Dagnostics for Haemostasis Market Size 2027-2032 ($ millions)
Figure 64. Japan In Vitro Dagnostics for Haemostasis Market Size 2027-2032 ($ millions)
Figure 65. Korea In Vitro Dagnostics for Haemostasis Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia In Vitro Dagnostics for Haemostasis Market Size 2027-2032 ($ millions)
Figure 67. India In Vitro Dagnostics for Haemostasis Market Size 2027-2032 ($ millions)
Figure 68. Australia In Vitro Dagnostics for Haemostasis Market Size 2027-2032 ($ millions)
Figure 69. Germany In Vitro Dagnostics for Haemostasis Market Size 2027-2032 ($ millions)
Figure 70. France In Vitro Dagnostics for Haemostasis Market Size 2027-2032 ($ millions)
Figure 71. UK In Vitro Dagnostics for Haemostasis Market Size 2027-2032 ($ millions)
Figure 72. Italy In Vitro Dagnostics for Haemostasis Market Size 2027-2032 ($ millions)
Figure 73. Russia In Vitro Dagnostics for Haemostasis Market Size 2027-2032 ($ millions)
Figure 74. Egypt In Vitro Dagnostics for Haemostasis Market Size 2027-2032 ($ millions)
Figure 75. South Africa In Vitro Dagnostics for Haemostasis Market Size 2027-2032 ($ millions)
Figure 76. Israel In Vitro Dagnostics for Haemostasis Market Size 2027-2032 ($ millions)
Figure 77. Turkey In Vitro Dagnostics for Haemostasis Market Size 2027-2032 ($ millions)
Figure 78. Global In Vitro Dagnostics for Haemostasis Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global In Vitro Dagnostics for Haemostasis Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries In Vitro Dagnostics for Haemostasis Market Size 2027-2032 ($ millions)

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同じKEY WORD()の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


LP Information社はどのような調査会社ですか?


LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。


詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

 

2026/11/20 10:25

160.51 円

176.53 円

212.83 円

ページTOPに戻る